相关实验视频

Updated: Jan 8, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

在癌症和非癌症个体中对eGFR进行比较研究:多中心分析

Baokui Ye^1,2, Xin Luo^2,3, Yunhan Luo^2,3

¹Department of Intensive Care Unit, Sun Yat-sen University Cancer Center, Guangzhou, China.

Frontiers in medicine

|December 22, 2025

概括

癌症患者的基线功能 (eGFR) 较高,但与健康个体相比,随着时间的推移,功能下降的速度更快. 这强调了在癌症治疗中需要仔细监测脏的必要性.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
在瘤学瘤学.
流行病学流行病学

背景情况:

由于治疗和疾病进展,癌症患者经常出现功能障碍.
了解功能 (eGFR) 变化对于治疗癌症患者至关重要.
基线和纵向eGFR数据对于有效的脏护理至关重要.

研究的目的:

为了比较基线估计的淋巴细胞过率 (eGFR) 和其在未经治疗的癌症患者与非癌症患者中的变化.
为了分析癌症对功能5年的影响.
为癌症患者提供关于脏健康管理的见解.

主要方法:

一项多中心研究包括24,478名未接受过治疗的癌症患者和61,883名非癌症患者.
使用CKD-EPI方程计算估计的淋巴球过率 (eGFR).
经过按年龄,性别和并发症分层进行比较后,进行了5年的随访.

主要成果:

癌症患者在所有年龄组的基线eGFR高于非癌症患者 (p <0.05).
癌症患者的中位体积也更大 (280厘米3比271厘米3,p <0.05).
在5年内,癌症患者的eGFR每年下降幅度显著增加 (p < 0.01).

结论:

以前没有接受过治疗的癌症患者在基线时表现出更高的eGFR,但随后的下降更为明显.
这些发现强调了监测癌症患者功能的重要性.
该研究观察到的关联,而不是因果关系,需要进一步调查.

关键词:

癌症癌症癌症癌症癌症美国GFRGFR 脏的体积大了,的体积大了.多中心研究多中心研究.瘤学在瘤学方面.

更多相关视频

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...